Jennifer Vance

Jennifer Vance currently serves as the Director of Bioanalysis and Biomarker Development at Recursion, a role held since February 2023. Prior to this position, Jennifer was the Associate Director of Account Management at Pharmaron from January 2022 to February 2023, and held various roles at AIT Bioscience, including Director and Associate Director of Scientific Services from July 2016 to January 2022. Jennifer's experience includes significant contributions to technical business management, sales, and scientific research across several organizations, including Phenomenex, ZDye/Montana State University, Schering-Plough, and Eli Lilly and Company. Jennifer earned a PhD in Organic Chemistry from Stanford University and holds a B.S. in Chemistry from Butler University, with additional studies in Chemistry and Biochemistry at the University of Glasgow.